The size of the global penicillin market is projected to be worth USD 1.9 billion in 2022 and rise at a compound annual growth rate of 3.8% to a readjusted USD 2.4 billion by 2028.

Penicillin market is experiencing this growth because of rise in investment in the activity of research & development of innovations for new product. In addition, the initiatives by government organization for creating awareness regarding controlling the bacterial infectious disease in people are projected to boost the growth of global penicillin market. The main challenge for the penicillin market is antibiotic resistance occurring in bacteria. Rise in the resistance to antibiotics is the main problem of public health across the world which is also the main factor affecting the growth of global penicillin market.

Penicillin are the group of antibiotics that consist benzathine penicillin (intramuscular mode), procaine penicillin, penicillin V (by mouth), penicillin G (intravenous mode). Penicillins are mostly used as the medications that are effective for bacterial infections occurring because of streptococci and staphylococci. The factors responsible for the growth of penicillin market are increase in investments for research & development, increase in occurrence of infectious diseases, government rules and innovations. Growth in the demand for the incidences of resistance for anti-microbial infections are responsible for the development and growth of the new products in the penicillin market. Strict rules of government are creating obstacles and patent expiry are the main challenges faced by the global penicillin market.

Many antibiotic products are using penicillin salts as main ingredient thus, manufacturing in China has the ability to affect API and prices of finished dose (FD) for the sources of company from China. Effect of the resources of reserve manufacturing, increase in strict rules will support the manufacturers of Chinese antibiotics will help to increase the penicillin market.

The main factors that are driving the growth of global penicillin market rise in the occurrence of the contagious disease and growth in the investments in the activities of research & development. Rise in demand for generic drugs are projected to boost the penicillin market growth. The reasons that may affect the growth is penicillin market growth are introducing the novel antibiotic which have less side effects and increase the antimicrobial resistance of microorganisms. Development of new product and use penicillin in cell cultures as the antibacterial agent are anticipated to offer opportunities for the growth of global penicillin market.

Global penicillin market segmentation is based on product types, mode of delivery, manufacturing procedure, end-user and region. On the basis of product types, penicillin market is divided into natural penicillin, aminopenicillins, penicillinase resistant penicillin, beta-lactamase inhibitors and anti-pseudomonal penicillins. By mode of delivery, market is divided into intravenous, intramuscular and oral. On considering the manufacturing procedure, market is divided into semi-synthetic process, natural process and synthetic process. By end-user, market is segmented into research institutes, clinics, hospitals and many more.

Geographically, regions involved in the development of penicillin market size are Europe, North America, Asia Pacific and LAMEA. Asia Pacific is the region that holds maximum amount of penicillin market share and is propelled to increase in the coming years.

Key players involved in the development of global penicillin market are DSM Sinochem Pharmaceuticals, Aurobindo, Antibioticos, Hindustan Antibiotics and GlaxoSmithKline.

Penicillin Market Scope

Key Segments in the “Global Penicillin Market” report are:

By Product Type, market is segmented into:

• Natural penicillin
• Aminopenicillins
• Penicillinase resistant penicillin
• Beta-lactamase inhibitors
• Anti-pseudomonal penicillins

By Mode of Delivery, market is segmented into:

• Intravenous
• Intramuscular
• Oral

By Manufacturing Procedure, market is segmented into:

• Semi-synthetic process
• Natural process
• Synthetic process

By End-User, market is segmented into:

• Research Institutes
• Clinics
• Hospitals
• Others

By Region, market is segmented into:

• Europe
• North America
• Asia Pacific
• LAMEA